Tunicamycin
{{cs1 config|name-list-style=vanc}}
{{chembox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 373567696
| ImageFile = Tunicamycin.svg
| ImageSize = 250px
| IUPACName = (E)-N-[(2S,3R,4R,5R,6R)-2-[(2R,3R,4R,5S,6R)-
3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-
6-[2-[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-
3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl]-4,5-dihydroxyoxan-
3-yl]-5-methylhex-2-enamide
| SystematicName =
| OtherNames = NSC 177382
|Section1={{Chembox Identifiers
| Abbreviations =
| CASNo_Ref = {{cascite|correct|CAS}}
| CASNo = 11089-65-9
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 505513
| ChemSpiderID = 24664016
| EINECS = 601-012-4
| PubChem = 6433557
| RTECS =
| MeSHName = Tunicamycin
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 55W4525Q2E
| StdInChI=1S/C30H46N4O16/c1-11(2)5-4-6-16(38)32-19-23(43)20(40)14(47-29(19)50-28-18(31-12(3)36)22(42)21(41)15(10-35)48-28)9-13(37)26-24(44)25(45)27(49-26)34-8-7-17(39)33-30(34)46/h4,6-8,11,13-15,18-29,35,37,40-45H,5,9-10H2,1-3H3,(H,31,36)(H,32,38)(H,33,39,46)/b6-4+/t13?,14-,15-,18-,19-,20+,21-,22-,23-,24+,25-,26-,27-,28-,29+/m1/s1
| StdInChIKey = ZHSGGJXRNHWHRS-VIDYELAYSA-N
| SMILES = CC(C)C\C=C\C(=O)N[C@@H]1[C@H]([C@H]([C@H](O[C@H]1O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)NC(=O)C)CC([C@@H]3[C@H]([C@H]([C@@H](O3)N4C=CC(=O)NC4=O)O)O)O)O)O
}}
|Section2={{Chembox Properties
| Formula = C39H64N4O16
| MolarMass = N/A
| Appearance =
| Density =
| MeltingPt =
| MeltingPt_notes =
| Solubility =
| SolubleOther =
| Solvent =
| pKa =
| pKb = }}
|Section7={{Chembox Hazards
| ExternalSDS =
| MainHazards =
| NFPA-H =
| NFPA-F =
| NFPA-R =
| NFPA-S =
| GHSPictograms = {{GHS06}}
| GHSSignalWord = Danger
| HPhrases = {{H-phrases|300}}
| PPhrases = {{P-phrases|}}
| FlashPt =
| AutoignitionPt =
| ExploLimits =
| LD50 =
| PEL = }}
|Section8={{Chembox Related
| OtherAnions =
| OtherCations =
| OtherFunction =
| OtherFunction_label =
| OtherCompounds = }}
}}
{{technical|date=October 2020}}
Tunicamycin is a mixture of homologous nucleoside antibiotics that inhibits the UDP-HexNAc: polyprenol-P HexNAc-1-P family of enzymes. In eukaryotes, this includes the enzyme GlcNAc phosphotransferase (GPT), which catalyzes the transfer of N-acetylglucosamine-1-phosphate from UDP-N-acetylglucosamine to dolichol phosphate in the first step of glycoprotein synthesis. Tunicamycin blocks N-linked glycosylation (N-glycans) and treatment of cultured human cells with tunicamycin causes cell cycle arrest in G1 phase. It is used as an experimental tool in biology, e.g. to induce unfolded protein response.{{cite journal|vauthors=Chan SW, Egan PA|title=Hepatitis C virus envelope proteins regulate CHOP via induction of the unfolded protein response|journal=The FASEB Journal|volume=19|issue=11|year=2005|pages=1510–1512|doi=10.1096/fj.04-3455fje|doi-access=free |pmid=16006626}} Tunicamycin is produced by several bacteria, including Streptomyces clavuligerus and Streptomyces lysosuperificus.
Tunicamycin homologues have varying molecular weights owing to the variability in fatty acid side chain conjugates.[http://www.sigmaaldrich.com/etc/medialib/docs/Sigma/Product_Information_Sheet/1/t7765pis.Par.0001.File.tmp/t7765pis.pdf] Tunicamycin product details]
Biosynthesis
The biosynthesis of tunicamycins was studied in Streptomyces chartreusis and a proposed biosynthetic pathway was characterized. The bacteria utilize the enzymes in the tun gene cluster (TunA-N) to make tunicamycins.{{cite journal |last1=Wyszynski |first1=Filip |last2=Hesketh |first2=Andrew |last3=Bibb |first3=Mervyn |last4=Davis |first4=Benjamin |date=2010 |title=Dissecting tunicamycin biosynthesis by genome mining: cloning and heterologous expression of a minimal gene cluster |journal=Chemical Science |volume=1 |issue=5 |pages=581 |doi=10.1039/c0sc00325e}}
TunA uses the starter unit uridine diphosphate-N-acetyl-glucosamine (UDP-GlcNAc) and catalyzes the dehydration of the 6’ hydroxyl group. First, a Tyr residue in TunA abstracts a proton from the 4’ hydroxyl group, forming a ketone at that position. A hydride is subsequently abstracted from the 4’ carbon by NAD+, forming NADH. The ketone is stabilized by hydrogen bonding from the Tyr residue, and a nearby Thr residue. A glutamate residue then abstracts a proton from the 5’ carbon, pushing the electrons up to form a double bond between the 5’ and 6’ carbon. A nearby cysteine donates a proton to the hydroxyl group as it leaves as water. NADH donates a hydride to the 4’ carbon, reforming a hydroxide in that position and forming UDP-6’-deoxy-5-6-ene-GlcNAc. TunF then catalyzes the epimerization of the intermediate to UDP-6’-deoxy-5-6-ene-GalNAc, changing the 4’ hydroxyl from the equatorial to axial position.{{cite journal |last1=Wyszynski |first1=Filip |last2=Lee |first2=Seung |last3=Yabe |first3=Tomoaki |last4=Wang |first4=Hua |last5=Gomez-Escribano |first5=Juan Pablo |last6=Bibb |first6=Mervyn |date=July 2012 |title=Biosynthesis of the tunicamycin antibiotics proceeds via unique exo-glycal intermediates |journal=Nature Chemistry |volume=4 |issue=7 |pages=539–546 |doi=10.1038/nchem.1351 |pmid=22717438|bibcode=2012NatCh...4..539W }}
The other starter unit for tunicamycin is uridine, which is produced from uridine triphosphate (UTP). TunN is a nucleotide diphosphatase, and catalyzes the removal of pyrophosphate from UTP to form uridine monophosphate. The last phosphate is removed by the putative monophosphatase, TunG.
Once uridine and UDP-6’-deoxy-5-6-ene-GalNAc are produced, TunB catalyzes their linkage at the 6’ carbon of UDP-6’-deoxy-5-6-ene-GalNAc. TunB uses S-adenyslmethionine (SAM) to form a radical on the 5’ carbon of the ribose on uracil. TunM is thought to catalyze the formation of a new bond between the 5’ carbon of uridine and the 6’ carbon of UDP-6’-deoxy-5-6-ene-GalNAc using the electron from the uridine radical and one of the electrons from the double bond of UDP-6’-deoxy-5-6-ene-GalNAc. The radical on UDP-6’-deoxy-5-6-ene-GalNAc is then quenched by abstracting a hydrogen from SAM.{{cite journal |last1=Giese |first1=Bernd |date=August 1989 |title=The Stereoselectivity of Intermolecular Free Radical Reactions [New Synthetic Methods (78)] |journal=Angewandte Chemie International Edition in English |volume=28 |issue=8 |pages=969–980 |doi=10.1002/anie.198909693}} The resulting molecule is UDP-N-acetyl-tunicamine. TunH then catalyzes the hydrolysis of UDP from UDP-N-acetyl-tunicamine. Another molecule of UDP-GlcNAc is introduced, and a β-1,1 glycosidic bond is subsequently formed, catalyzed by TunD. The resulting molecule is deacetylated by TunE. TunL and a fatty acyl-ACP ligase are used to load metabolic fatty acids onto the acyl carrier protein, TunK. TunC then attaches the fatty acid to the free amine, producing tunicamycin.
See also
- Glycosylation - tunicamycin blocks all N-glycosylation of proteins
- Glycoprotein
- Streptomyces
References
{{reflist}}
External links
- Book section of Essentials in Glycobiology (1999) [https://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=glyco.section.3051 Tunicamycin: Inhibition of DOL-PP-GlcNAc Assembly]